Abstract
Interactions between the pharmaceutical industry and physicians have recently received attention for their potential to create conflicts of interest in clinical practice, research and education. As a consequence, several medical and psychiatric associations including the EPA have published guidance papers to encourage best practice. In this context, the European Federation of Psychiatric Trainees (EFPT) performed a cross-sectional survey among European psychiatric trainees in order to ascertain the current level of interactions, as well as beliefs and attitudes towards interactions with the pharmaceutical industry. Responses from 1444 psychiatric trainees from 20 countries were obtained and reveal important differences in the level of interactions across Europe. Assigning a an educational role to the pharmaceutical industry and aid by senior psychiatrists in organizining industry-sponsored events were associated with a higher degree of interactions. Creating alternative, non-industry-sponsored educational opportunities and specific training dedicated to industry interactions may help to reduce the impact of the pharmaceutical industry on psychiatric training in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
